Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

7.89
Delayed Data
As of 3:59pm ET
 +0.19 / +2.47%
Today’s Change
4.00
Today|||52-Week Range
11.72
-8.68%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$540.5M

Company Description

Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipelines are therapeutic agents, imaging agents for prostate cancer, and imaging analysis tools. The company was founded by Paul J. Maddon in 1986 and is headquartered in Tarrytown, NY.

Contact Information

Progenics Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown New York 10591
P:(646) 975-2500
Investor Relations:

Employees

Shareholders

Mutual fund holders53.59%
Other institutional30.49%
Individual stakeholders12.35%

Top Executives

Mark Robert BakerChief Executive Officer & Director
Meryl J. LongvalVice President-Operations
Patrick FabbioCFO, Principal Accounting Officer & Senior VP
Thomas StrackVice President-Clinical Affairs
Vivien WongVice President-Product Development